Journal of the Neurological Sciences
Volume 247, Issue 2 , Pages 157-164 , 25 September 2006

The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy

  • Marion Deon

      Affiliations

    • Serviço de Genética Médica, HCPA, Porto Alegre, RS, Brazil
    • Departamento de Bioquímica, ICBS, UFRGS, Porto Alegre, RS, Brazil
    • Corresponding Author InformationCorresponding authors. Medical Genetics Service, HCPA, Rua Ramiro Barcelos, 2350 CEP 90.035-003, Porto Alegre, RS, Brazil. Tel.: +55 51 21018011; fax: +55 51 21018010.
    • ,
  • Moacir Wajner

      Affiliations

    • Serviço de Genética Médica, HCPA, Porto Alegre, RS, Brazil
    • Departamento de Bioquímica, ICBS, UFRGS, Porto Alegre, RS, Brazil
    • ,
  • Lisana R. Sirtori

      Affiliations

    • Serviço de Genética Médica, HCPA, Porto Alegre, RS, Brazil
    • ,
  • Douglas Fitarelli

      Affiliations

    • Serviço de Genética Médica, HCPA, Porto Alegre, RS, Brazil
    • ,
  • Daniella M. Coelho

      Affiliations

    • Serviço de Genética Médica, HCPA, Porto Alegre, RS, Brazil
    • ,
  • Angela Sitta

      Affiliations

    • Serviço de Genética Médica, HCPA, Porto Alegre, RS, Brazil
    • Departamento de Bioquímica, ICBS, UFRGS, Porto Alegre, RS, Brazil
    • ,
  • Alethéa G. Barschak

      Affiliations

    • Departamento de Análises Clínicas, Faculdade de Farmácia, UFRGS, Porto Alegre, RS, Brazil
    • Departamento de Bioquímica, ICBS, UFRGS, Porto Alegre, RS, Brazil
    • ,
  • Gustavo C. Ferreira

      Affiliations

    • Departamento de Bioquímica, ICBS, UFRGS, Porto Alegre, RS, Brazil
    • ,
  • Alexsandro Haeser

      Affiliations

    • Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, UFRGS, Brazil
    • ,
  • Roberto Giugliani

      Affiliations

    • Serviço de Genética Médica, HCPA, Porto Alegre, RS, Brazil
    • ,
  • Carmen R. Vargas

      Affiliations

    • Departamento de Análises Clínicas, Faculdade de Farmácia, UFRGS, Porto Alegre, RS, Brazil
    • Serviço de Genética Médica, HCPA, Porto Alegre, RS, Brazil
    • Departamento de Bioquímica, ICBS, UFRGS, Porto Alegre, RS, Brazil
    • Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, UFRGS, Brazil
    • Corresponding Author InformationCorresponding authors. Medical Genetics Service, HCPA, Rua Ramiro Barcelos, 2350 CEP 90.035-003, Porto Alegre, RS, Brazil. Tel.: +55 51 21018011; fax: +55 51 21018010.

Received 19 September 2005 ,Revised 7 February 2006 ,Accepted 10 April 2006.

References 

  1. Wanders RJA, Van Roermund CWT, Schutgens RBH, Barth PG, Heymans HS, Van Den Bosch H, et al. The inborn errors of peroxisomal β-oxidation. J Inherit Metab Dis. 1990;13:04–36
  2. Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomieloneuropathy. Dev Neurosci. 1991;13(4,5):254–261
  3. Wanders RJA, Van Roermund CWT, Lageweg W, Jakobs BS, Schutgens RBH, Nijenheis AA, et al. X-linked adrenoleukodystrophy: biochemical diagnosis and enzyme defect. J Inherit Metab Dis. 1992;15:634–644
  4. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser HW, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993;361:726–730
  5. Wanders RJA, Vreken P, Ferdinandusse S, Jassen GA, Waterham R, Van Roermund CWT, et al. Peroxisomal fatty acid α- and β-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans. 2001;29(2):250–267
  6. Moser HW, Smith KD, Watkins PA, Powers J, Moser AB. X-linked adrenoleukodystrophy. In:  Scriver CR,  Beaudet AL,  Sly WS,  Valle D editor. The metabolic and molecular bases of inherited disease. 8th ed.. New York: McGraw-Hill Inc.; 2001;
  7. Koike R, Tsuji S, Ohno T, Suzuki Y, Orri T, Miyatake T. Physiological significance of fatty acid elongation system in adrenoleukodystrophy. J Neurol Sci. 1991;103:188–196
  8. Wanders RJA, Barth PG, Schutgens RBH, Tager JM. Clinical and biochemical characteristics of peroxisomal disorders: an update. Eur J Pediatr. 1994;153(Suppl. 1):S44–S48
  9. Korenke GC, Hunneman DH, Kohler J, Stöcker S, Landmark K, Hanefeld F. Glyceroltrioleate/ glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/ adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters. Eur J Pediatr. 1995;154:64–70
  10. Wanders RJA, Schutgens RBH, Barth PG. Peroxisomal disorders: a review. J Neuropathol Exp Neurol. 1995;17:726–739
  11. Wanders RJA, Van Grunsven EG, Jassen GA. Lipid metabolism in peroxisomes: enzymology, functions and dysfunctions of the fatty acid α- and β-oxidation system in humans. Biochem Soc Trans. 2000;28(2):141–148
  12. Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. 2004 (Aug 1);104(3):881–888
  13. Van Geel BM, Assies J, Wanders RJ, Barth PG. X-linked adrenoleukodystrohy: clinical presentation, diagnosis, and therapy. J Neurol Neurosurg Psychiatry. 1997;63(1):4–14
  14. Pujol A, Hindelang C, Callizot N, Bartsch U, Schaschner M, Mandel JL. Late onset neurological phenotype of X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet. 2002;11(05):499–505
  15. Moser HW. Adrenoleukodystrophy: natural history, treatment, and outcome. J Inherit Metab Dis. 1995;18:435–447
  16. Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain. 1997;120:1485–1508
  17. Scriver CR, Beaudet AL, Sly WS, Valle D. The metabolic and molecular bases of inherited disease. 8th ed.. New York: McGraw-Hill Inc.; 2001;
  18. Restuccia D, Di Lazzaro V, Valeriani M, Oliviero A, Le Pera D, Barba C, et al. Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleukodystrophy. Neurology. 1999 (Augusto);52:810–815
  19. Moser HW, Raymond GV, Lu SE, Muenz LR, Moser AB, Xu J, et al. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil. Arch Neurol. 2005;62(7):1073–1080
  20. Singh I, Khan M, Key L, Pai S. Lovastatin for X-linked adrenoleukodystrophy. N Engl J Med. 1998;339(10):702–703
  21. Singh I, Pahan K, Khan M. Lovastatin and sodium phenylacetate normalise the levels of very long chain fatty acids in skin fibroblasts of X-adrenoleukodystrophy. FEBS Lett. 1998;426:342–346
  22. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95
  23. In:  Halliwell B,  Gutteridge JMC editor. Free radicals in biology and medicine. 3rd edition. Oxford: Oxford University Press; 2001;
  24. Vargas CR, Wajner M, Sirtori LR, Goulart L, Chiochetta M, Coelho D, et al. Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta. 2003;1688:26–32
  25. Moser HW, Moser AB. Measurement of saturated very long chain fatty acid in plasma. In:  Hommes FA editors. Techniques in diagnostics human biochemical genetics. New York: Wiley-Liss; 1991;p. 177–191
  26. Bioukar EB, Straehli F, Heng Ng K, Rolland MO, Hashimoto T, Carreau JP, et al. Resistance to erucic acid as a selectable marker for peroxissomal activity: isolation of revertants of an infantile Refsum Disease cell line. J Inherit Metab Dis. 1994;17:41–59
  27. Gonzalez-Flecha B, Llesuy S, Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver and muscle. Free Radic Biol Med. 1991;10:93–100
  28. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407–421
  29. Lissi E, Pascual C, Del Castillo MD. Luminol luminescence induced by 2,2′-azo-bis-(2-amidinopropane) thermolysis. Free Radic Res Commun. 1992;17:299–311
  30. Aebi H. In:  Bergmeyer HU,  Bergmeyer J,  Grabl M editor. Methods of enzymatic analysis. 3rd ed.. 1983;p. 273–296
  31. Wendel A. Glutathione peroxidase. Methods Enzymol. 1981;77:325–332
  32. Lowry OH, Rosebrough NJ, Lewis-Farr A, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275
  33. Mcguinness MC, Wesselingh SL, Griffin DE, Powers JM, Moser HW, Smith KD. Cytokines and inflammatory demyelinative lesions in adrenoleukodystrophy and multiple sclerosis. J Neuropathol Exp Neurol. 1993;52:331–341

PII: S0022-510X(06)00166-3

doi: 10.1016/j.jns.2006.04.004

Journal of the Neurological Sciences
Volume 247, Issue 2 , Pages 157-164 , 25 September 2006

Article Tools

* Image Usage & Resolution